This content was released on 11/12/2019 and will expire on 11/12/2020.
Explore treatment decisions surrounding SGLT2 inhibitors, including when they are recommended and how to select between them.
The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.
This content was released on 11/12/2019 and will expire on 11/12/2020.
Guidelines from the ESC, published September 2019, include recommendations regarding first-line monotherapy that have proven divisive among the expert community. Hear from international experts on when and how to implement these recommendations in practice.
The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.
This content was released on 11/12/2019 and will expire on 11/12/2020.
Consider combination therapy approaches in a patient with established renal failure and elevated cardiovascular risk.
The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change.